aripiprazole has been researched along with Borderline Personality Disorder in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Benites-Zapata, VA; Campos-Rodriguez, SK; Fernández, MF; Ortiz-Saavedra, B; Pino-Zavaleta, DA; Valdivieso-Jiménez, G | 1 |
| Bartholomeusz, C; Betts, J; Bhaduri, A; Chanen, AM; Cotton, SM; Davey, C; Francey, S; Jackson, H; Jovev, M; Lowe, D; McCutcheon, L; McGorry, P; Nelson, B; Pantelis, C; Ratheesh, A; Rayner, V; Thompson, K | 1 |
| Caballero, AR; Martínez, JS | 1 |
| Azorin, JM; Camus, V; Costentin, J; Crocq, MA; Daléry, J; Gliskman, J; Krebs, MO; Limosin, F; Millet, B | 1 |
| Bellino, S; Bogetto, F; Paradiso, E | 1 |
| Rittmannsberger, H; Werl, R | 1 |
| Cottencin, O; Geoffroy, PA; Guardia, D; Rolland, B; Warembourg, F | 1 |
| Anvar, J; Bachler, E; Buschmann, W; Egger, C; Fartacek, R; Kaplan, P; Kettler, C; Loew, TH; Muehlbacher, M; Nickel, C; Nickel, MK; Pedrosa Gil, F; Rother, N; Rother, WK | 1 |
| Malevani, J; Mobascher, A; Mobascher, J; Schlemper, V; Winterer, G | 1 |
| Loew, TH; Nickel, MK; Pedrosa Gil, F | 1 |
| Kellner, M | 1 |
| Nickel, MK | 1 |
2 review(s) available for aripiprazole and Borderline Personality Disorder
| Article | Year |
|---|---|
Efficacy and Safety of Aripiprazole in Borderline Personality Disorder: A Systematic Review.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Borderline Personality Disorder; Female; Humans; Male; Olanzapine | 2023 |
[Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature].
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Depressive Disorder, Major; Humans; Mental Disorders; Neurodegenerative Diseases; Parkinson Disease; Piperazines; Quinolones; Schizophrenia; Substance-Related Disorders; Tourette Syndrome | 2008 |
3 trial(s) available for aripiprazole and Borderline Personality Disorder
| Article | Year |
|---|---|
Aripiprazole compared with placebo for auditory verbal hallucinations in youth with borderline personality disorder: Protocol for the VERBATIM randomized controlled trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Australia; Borderline Personality Disorder; Female; Hallucinations; Humans; Male; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2019 |
Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.
Topics: Aggression; Anger; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Double-Blind Method; Female; Humans; Male; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Severity of Illness Index; Suicide; Surveys and Questionnaires; Treatment Outcome | 2006 |
Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up.
Topics: Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Female; Follow-Up Studies; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Research Design; Time Factors; Treatment Outcome | 2007 |
7 other study(ies) available for aripiprazole and Borderline Personality Disorder
| Article | Year |
|---|---|
Long-Acting Aripiprazole in Comorbid Bipolar Disorder and Borderline Personality Disorder and Substance Abuse.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Borderline Personality Disorder; Comorbidity; Humans; Male; Substance-Related Disorders | 2017 |
Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Anxiety; Aripiprazole; Borderline Personality Disorder; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Drug Therapy, Combination; Headache; Humans; Middle Aged; Personality Inventory; Piperazines; Psychiatric Status Rating Scales; Quinolones; Sertraline; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2008 |
Does aripiprazole protect from serotonin syndrome?
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Tremor; Venlafaxine Hydrochloride; Young Adult | 2012 |
Use of aripiprazole in treatment of cannabis dependence in a patient presenting with Borderline Personality Disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Diagnosis, Dual (Psychiatry); Female; Humans; Marijuana Abuse; Piperazines; Quinolones | 2012 |
Aripiprazole pharmacotherapy of borderline personality disorder.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypotension, Orthostatic; Personality Assessment; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Quinolones | 2006 |
Aripiprazole in a therapy-resistant patient with borderline personality and post-traumatic stress disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Drug Resistance; Female; Humans; Piperazines; Psychiatric Status Rating Scales; Quinolones; Stress Disorders, Post-Traumatic | 2007 |
Aripiprazole treatment of patients with borderline personality disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Male; Piperazines; Quinolones; Severity of Illness Index | 2007 |